Literature DB >> 24898650

Modulation of amyloid-β protein precursor expression by HspB1.

Megan Conway1, Firoozeh Nafar1, Tatjana Straka1, Karen Mearow1.   

Abstract

Upregulation of heat shock proteins, such as Hsp70 and HspB1/Hsp27, have been associated with an amelioration of the deficits in animal models of Alzheimer's disease (AD). HspB1 is reported to be increased in AD brains and to accumulate in plaques, but whether this localization is an attempt by HspB1 to ameliorate the detrimental effects of amyloid-β (Aβ) on cells or part of the disease process is unknown. Here we explore the potential effects of the HspB1 on amyloid-β protein precursor (AβPP) processing and distribution within HEK293 stable cell lines expressing either AβPPwt or AβPPsw. We compare AβPP production, distribution, and release of proteolytic products (including Aβ40 and Aβ42) to determine possible modifications in the presence of HspB1. We also investigate whether HspB1 interacts with Aβ or its precursor, AβPP, and whether, through this interaction, it is able to alter AβPP processing or release of Aβ peptide. Coexpression of HspB1 resulted in increased cellular holoAβPP as well as C-terminal fragments. Further, expression of HspB1 attenuated the release of Aβ42 from the AβPPsw cells. In summary, we have shown that expression of HspB1 alters AβPP expression and processing in cell lines expressing AβPPwt and AβPPsw. Furthermore, the presence of HspB1 decreased the amount of Aβ42 released by the cell lines. Thus in addition to its effects on protecting cells from the potentially toxic effects of Aβ, HspB1 also appears to be involved in modulating cellular levels of AβPP, although an understanding of the underlying mechanisms requires further investigation.

Entities:  

Keywords:  AβPPsw; AβPPwt; cell line; protein expression; small heat shock protein

Mesh:

Substances:

Year:  2014        PMID: 24898650     DOI: 10.3233/JAD-140348

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  3 in total

1.  Multiscale causal networks identify VGF as a key regulator of Alzheimer's disease.

Authors:  Noam D Beckmann; Wei-Jye Lin; Minghui Wang; Ariella T Cohain; Alexander W Charney; Pei Wang; Weiping Ma; Ying-Chih Wang; Cheng Jiang; Mickael Audrain; Phillip H Comella; Amanda K Fakira; Siddharth P Hariharan; Gillian M Belbin; Kiran Girdhar; Allan I Levey; Nicholas T Seyfried; Eric B Dammer; Duc Duong; James J Lah; Jean-Vianney Haure-Mirande; Ben Shackleton; Tomas Fanutza; Robert Blitzer; Eimear Kenny; Jun Zhu; Vahram Haroutunian; Pavel Katsel; Sam Gandy; Zhidong Tu; Michelle E Ehrlich; Bin Zhang; Stephen R Salton; Eric E Schadt
Journal:  Nat Commun       Date:  2020-08-07       Impact factor: 14.919

2.  A Novel Heterozygous Missense Variant in the CIAO1 Gene in a Family with Alzheimer's Disease: The Val67Ile Variant Promotes the Interaction of CIAO1 and Amyloid-β Protein Precursor.

Authors:  Haitian Nan; Yeon-Jeong Kim; Mai Tsuchiya; Toko Fukao; Noriko Hara; Atsushi Hagihara; Kenya Nishioka; Nobutaka Hattori; Norikazu Hara; Takeshi Ikeuchi; Toshihisa Ohtsuka; Yoshihisa Takiyama
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  An immune response characterizes early Alzheimer's disease pathology and subjective cognitive impairment in hydrocephalus biopsies.

Authors:  Wenrui Huang; Anne Marie Bartosch; Harrison Xiao; Suvrajit Maji; Elliot H H Youth; Xena Flowers; Sandra Leskinen; Zeljko Tomljanovic; Gail Iodice; Deborah Boyett; Eleonora Spinazzi; Vilas Menon; Robert A McGovern; Guy M McKhann; Andrew F Teich
Journal:  Nat Commun       Date:  2021-09-27       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.